Volgen
Michał Łaźniewski
Michał Łaźniewski
Geverifieerd e-mailadres voor pw.edu.pl
Titel
Geciteerd door
Geciteerd door
Jaar
Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database
D Plewczynski, M Łaźniewski, R Augustyniak, K Ginalski
Journal of computational chemistry 32 (4), 742-755, 2011
3732011
Detailed mechanism of squalene epoxidase inhibition by terbinafine
M Nowosielski, M Hoffmann, LS Wyrwicz, P Stepniak, DM Plewczynski, ...
Journal of chemical information and modeling 51 (2), 455-462, 2011
1052011
VoteDock: consensus docking method for prediction of protein–ligand interactions
D Plewczynski, M Łażniewski, MV Grotthuss, L Rychlewski, K Ginalski
Journal of computational chemistry 32 (4), 568-581, 2011
962011
C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3′ end modification
S Mroczek, J Krwawicz, J Kutner, M Lazniewski, I Kuciński, K Ginalski, ...
Genes & development 26 (17), 1911-1925, 2012
772012
Unfolding the mechanism of the AAA+ unfoldase VAT by a combined cryo-EM, solution NMR study
R Huang, ZA Ripstein, R Augustyniak, M Lazniewski, K Ginalski, LE Kay, ...
Proceedings of the National Academy of Sciences 113 (29), E4190-E4199, 2016
552016
The structural variability of the influenza A hemagglutinin receptor-binding site
M Lazniewski, WK Dawson, T Szczepińska, D Plewczynski
Briefings in functional genomics 17 (6), 415-427, 2018
362018
Novel neuro-audiological findings and further evidence for TWNK involvement in Perrault syndrome
M Ołdak, D Oziębło, A Pollak, I Stępniak, M Lazniewski, U Lechowicz, ...
Journal of Translational Medicine 15 (1), 1-13, 2017
352017
RNA structure interactions and ribonucleoprotein processes of the influenza A virus
WK Dawson, M Lazniewski, D Plewczynski
Briefings in functional genomics 17 (6), 402-414, 2018
222018
A heterozygous mutation in GOT1 is associated with familial macro-aspartate aminotransferase
M Kulecka, A Wierzbicka, A Paziewska, M Mikula, A Habior, W Janczyk, ...
Journal of hepatology 67 (5), 1026-1030, 2017
192017
Novel transmembrane lipases of alpha/beta hydrolase fold
M Lazniewski, K Steczkiewicz, L Knizewski, I Wawer, K Ginalski
FEBS letters 585 (6), 870-874, 2011
162011
One protein to rule them all: The role of CCCTC-binding factor in shaping human genome in health and disease
M Lazniewski, WK Dawson, AM Rusek, D Plewczynski
Seminars in cell & developmental biology 90, 114-127, 2019
142019
Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells
AA Marusiak, MK Prelowska, D Mehlich, M Lazniewski, K Kaminska, ...
Oncogene 38 (15), 2860-2875, 2019
142019
Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations
E Ciara, D Rokicki, M Lazniewski, H Mierzewska, E Jurkiewicz, ...
Journal of human genetics 63 (4), 473-485, 2018
142018
Binding Activity Prediction of Cyclin-Dependent Inhibitors
I Saha, B Rak, SS Bhowmick, U Maulik, D Bhattacharjee, U Koch, ...
Journal of chemical information and modeling 55 (7), 1469-1482, 2015
102015
Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells
J Chlebowska-Tuz, O Sokolowska, P Gaj, M Lazniewski, M Firczuk, ...
haematologica 103 (11), 1843, 2018
92018
PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress
M Klopotowska, M Bajor, A Graczyk-Jarzynka, A Kraft, Z Pilch, A Zhylko, ...
Cancer immunology research, 2021
52021
3DFlu: database of sequence and structural variability of the influenza hemagglutinin at population scale
G Mazzocco, M Lazniewski, P Migdał, T Szczepińska, JP Radomski, ...
Database 2016, 2016
52016
Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations
M Lazniewski, D Dermawan, S Hidayat, M Muchtaridi, W Dawson, ...
Methods, 2022
42022
Potent but transient immunosuppression of T-cells is a general feature of erythroid progenitor cells
TM Grzywa, A Sosnowska, Z Rydzynska, M Lazniewski, D Plewczynski, ...
bioRxiv, 2021
42021
Novel COL12A1 variant as a cause of mild familial extracellular matrix-related myopathy
A Jezela-Stanek, A Walczak, M Łaźniewski, J Kosińska, P Stawiński, ...
Clinical genetics 95 (6), 736-738, 2019
42019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20